Ultragenyx Pharmaceutical Inc. buy Royal Bank of Canada
Start price
06.11.24
/
50%
€47.00
Target price
06.11.25
€71.64
Performance (%)
-42.98%
End price
07.11.25
€26.80
Summary
This prediction ended on 07.11.25 with a price of €26.80. Massive losses of -42.98% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -0.950% | -0.950% | -8.200% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $77.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€31.15
07.07.26
07.07.26
€34.97
07.07.27
07.07.27
-27.51%
08:32
08:32
Stopped prediction by Royal_Bank_of_Canada for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.00
26.09.24
26.09.24
€69.10
26.09.25
26.09.25
-49.39%
27.09.25
27.09.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
22.04.24
22.04.24
€72.35
22.04.25
22.04.25
-22.82%
23.04.25
23.04.25